A 50mg mass-spec vial of TB-500 (synthetic Thymosin Beta-4 fragment) provides a high-yield lyophilized cake tailored for continuous in vitro assays and high-throughput animal model research. This technical guide outlines chemical characteristics, precise reconstitution math across multiple volume diluents, aliquot management protocols, and analytical quality metrics.
A 50mg mass-spec vial of TB-500 (synthetic Thymosin Beta-4 fragment) provides a high-yield lyophilized cake tailored for continuous in vitro assays and high-throughput animal model research. This technical guide outlines chemical characteristics, precise reconstitution math across multiple volume diluents, aliquot management protocols, and analytical quality metrics.
TB-500 is a synthetic peptide variant containing the active functional sequence of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide involved in actin sequestration, cellular migration, and tissue repair. The 50mg mass presentation is designed specifically for academic institutions, contract research organizations (CROs), and industrial laboratories carrying out large-scale preclinical studies where low-mass vials (such as 2mg or 5mg) require overly frequent reconstitution steps.
While PX1 Research routinely stocks the standard research package—the TB-500 (Thymosin Beta-4) 10mg vial for precise single-assay sets—higher mass allocations such as 50mg are frequently utilized in multi-well microplate cell migration assays and longitudinal rodent tissue injury models. Researchers evaluating bulk procurement, multi-vial series, or alternative volumetric configurations can review our full catalog via /all-peptides or consult our institutional account specialists.
TB-500 features the key acetylated N-terminal sequence Ac-SDKPD, along with the core actin-binding domain LKKTETQ derived from native Thymosin Beta-4. This primary structure governs its unique steric interactions with globular actin (G-actin) monomers within the eukaryotic cytoplasm.
Synthesized via automated solid-phase peptide synthesis (SPPS), high-purity TB-500 avoids biological contaminants common to extraction-based proteins. The resultant 50mg lyophilized powder consists of a refined, white, uniform cake with minimal salt adducts, providing high solubility in standard aqueous laboratory buffers like bacteriostatic water, sterile 0.9% sodium chloride, and phosphate-buffered saline (PBS).
In vitro data indicate that TB-500 acts primarily as a major G-actin sequestering peptide. By forming a 1:1 complex with monomeric actin, TB-500 maintains an intracellular pool of unpolymerized actin monomers, which dynamically fuels filament assembly (F-actin) at the leading edge of migrating cells during lamellipodia formation.
Preclinical studies suggest that this actin regulation promotes cellular motility, endothelial cell differentiation, and microvascular sprouting (angiogenesis). In rodent models of soft-tissue damage, synthetic Thymosin Beta-4 fragments have been investigated for promoting cell migration, blood-vessel formation, and structural flexibility during soft-tissue and muscle-fiber recovery without inducing persistent pro-inflammatory cascades.
Accurate reconstitution of a 50mg mass vial requires precise solvent-to-solute volumetric calculations to establish controlled stock concentrations. Because 50mg represents a substantially larger mass than standard analytical vials, diluent volume selection directly impacts pipetting precision and solution viscosity.
To achieve target working stock concentrations using common diluents (e.g., Bacteriostatic Water or Sterile Normal Saline):
1. Reconstitution with 1.0 mL Diluent: Concentration = 50 mg / 1.0 mL = 50.0 mg/mL (or 50.0 µg/µL). This hyper-concentrated stock is suitable for minimal-volume micro-injection setups or frozen master-stock preparation.
2. Reconstitution with 2.0 mL Diluent: Concentration = 50 mg / 2.0 mL = 25.0 mg/mL (or 25.0 µg/µL). This balanced concentration simplifies sub-aliquot pipetting for automated fluid-handling systems.
3. Reconstitution with 5.0 mL Diluent: Concentration = 50 mg / 5.0 mL = 10.0 mg/mL (or 10.0 µg/µL). A 10 mg/mL concentration allows highly accurate volumetric measurement for routine cell culture dosing.
4. Reconstitution with 10.0 mL Diluent: Concentration = 50 mg / 10.0 mL = 5.0 mg/mL (or 5.0 µg/µL). Recommended when large working volumes are needed across multi-well assays to prevent volumetric measurement error.
For quick automated conversion of mass-to-volume relationships, lab personnel should utilize our interactive /reconstitution-calculator prior to solvent introduction.
Repeated freeze-thaw cycles degrade peptide bond integrity, leading to aggregation, peptide cleavage, and loss of functional concentration in assay wells. Because a 50mg vial represents a significant quantity of research material, immediate master aliquoting post-reconstitution is critical.
Upon reconstitution with an appropriate sterile buffer, the primary stock solution should be divided into single-use microcentrifuge tubes (e.g., 50 µL to 200 µL per vial) in a laminar flow hood. Aliquots designated for short-term use (1–14 days) may be stored at 2°C to 8°C, while long-term experimental reserves must be immediately frozen at -20°C or -80°C. Avoid standard frost-free freezers, as their temperature cycles accelerate hydrolysis.
Selecting between a high-capacity 50mg vial and lower-mass alternatives depends on assay throughput, budget parameters, and shelf-life constraints. A 50mg vial reduces packaging overhead and batch-to-batch variation across extended testing protocols, making it ideal for high-throughput screening.
Conversely, when protocols require intermittent testing over several months, smaller units like the TB-500 (Thymosin Beta-4) 10mg format present less risk of solvent degradation or contamination over time. Labs carrying out small animal cohort pilot runs often prefer multiple 10mg vials to ensure fresh stock for each experimental block.
TB-500 is frequently evaluated alongside other tissue remodeling and extracellular matrix repair peptides in comparative preclinical research models. Understanding how TB-500 compares to related compounds helps investigators select optimal candidate molecules for specific biological pathways.
In soft-tissue and microvascular research, TB-500 is often studied in conjunction with BPC-157, a pentadecapeptide investigated for its nitric oxide modulation and tendon-to-bone junction cellular signaling. While TB-500 acts via actin monomer sequestration and endothelial cell motility, BPC-157 functions through distinct VEGFR2 upregulation pathways. Additionally, investigators frequently compare these compounds with GHK-Cu, a copper-binding tripeptide involved in collagen synthesis and gene transcript regulation, as well as anti-inflammatory peptides like KPV. Evaluating these mechanisms side by side allows for robust multi-pathway experimental design.
High-mass peptide vials require rigorous analytical validation to ensure purity remains uniform throughout the entire fill run. PX1 Research subjects every batch to rigorous analytical testing in ISO 17025 accredited partner laboratories.
Every lot is verified using High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeding 99.0%, combined with Mass Spectrometry (MS) to verify exact molecular weight. Crucially for cell culture and preclinical models, endotoxin levels are verified via Chromogenic LAL testing to remain strictly below institutional thresholds (< 0.01 EU/µg). Researchers can access batch-specific documentation on our central /coa repository.
Unreconstituted (lyophilized) TB-500 50mg vials should be stored at -20°C or lower upon receipt. Under desiccated, sub-zero conditions, the lyophilized cake maintains stability for up to 24 months. Protect vials from light exposure by storing them in original secondary packaging.
Once reconstituted, reconstituted aqueous solutions are sensitive to room temperature degradation. Always handle reconstituted vials using aseptic techniques inside a certified biosafety cabinet. For further details on analytical methods and storage science, explore our institutional resources at /research.
PX1 Research supplies high-purity peptides strictly for laboratory research, analytical testing, and preclinical development. Our supply chain operates from US-based facilities (California and Arizona) with same-day dispatch for orders placed before standard daily cutoffs.
Principal investigators, lab managers, and procurement officers setting up recurring orders, bulk material reserves, or specialized packaging configurations can request custom quotes through our dedicated /wholesale portal.
What is the primary difference between TB-500 and native Thymosin Beta-4?
Native Thymosin Beta-4 is a full-length 43-amino-acid protein. TB-500 typically refers to the synthetic peptide fragment containing the active actin-binding region (LKKTETQ domain) that reproduces the cellular migration and actin-sequestering properties of the parent molecule in preclinical models.
Does PX1 Research supply TB-500 in a 50mg single vial?
PX1 Research routinely stocks standard [TB-500 10mg](/product/tb-500-thymosin-beta-4-10mg) vials for standard laboratory workflows. 50mg configurations and high-volume mass allocations are available for custom institutional procurement through our [/wholesale](/wholesale) program.
How much Bacteriostatic Water should be added to a 50mg TB-500 vial?
Diluent volume depends on your target concentration. Adding 2.0 mL yields a concentration of 25 mg/mL (25 µg/µL), while 5.0 mL yields 10 mg/mL (10 µg/µL). You can calculate custom volumes using the [/reconstitution-calculator](/reconstitution-calculator).
How should a reconstituted 50mg stock solution be stored to prevent degradation?
After reconstitution, aliquot the solution into single-use tubes to avoid repeated freeze-thaw cycles. Store short-term working aliquots at 2°C to 8°C for up to 14 days, and freeze long-term aliquots at -20°C or -80°C.
What analytical parameters are documented on the PX1 Certificate of Analysis (COA)?
Each lot-matched COA includes RP-HPLC chromatograms showing purity (typically ≥99%), Mass Spectrometry confirming theoretical molecular weight, and LAL assay verification of low endotoxin content (<0.01 EU/µg). COAs can be downloaded via [/coa](/coa).
Can TB-500 be reconstituted in solvents other than Bacteriostatic Water?
Yes. Depending on assay specifications, sterile 0.9% sodium chloride (normal saline) or sterile phosphate-buffered saline (PBS, pH 7.4) may be used. If storing reconstituted solution for more than 24 hours at 4°C, a bacteriostatic agent (such as 0.9% benzyl alcohol) is recommended to prevent microbial growth.
What preclinical biological activities are investigated with TB-500?
Preclinical studies focus on TB-500's role in G-actin binding, endothelial cell migration, microvascular formation (angiogenesis), and extracellular matrix flexibility during soft-tissue structural repair assays.
Is TB-500 50mg suitable for human administration or clinical use?
No. All products offered by PX1 Research are strictly designated for in vitro, analytical, and laboratory research use only. They are not intended for human or veterinary administration, medical treatment, diagnosis, or therapeutic applications.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.